Guido Reifenberger Selected Research

Tumor Suppressor Protein p14ARF (p14ARF)

7/2009	Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.
11/2004	Molecular pathogenesis of meningiomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guido Reifenberger Research Topics

Disease

138	Neoplasms (Cancer) 05/2024 - 03/2002
101	Glioma (Gliomas) 05/2024 - 07/2002
99	Glioblastoma (Glioblastoma Multiforme) 05/2024 - 10/2002
40	Astrocytoma (Pilocytic Astrocytoma) 05/2024 - 10/2002
17	Brain Neoplasms (Brain Tumor) 10/2023 - 11/2006
14	Medulloblastoma 11/2023 - 10/2003
10	Oligodendroglioma 05/2024 - 02/2003
7	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2002
6	Meningioma (Meningiomas) 12/2021 - 04/2002
6	Carcinogenesis 01/2019 - 03/2004
5	Disease Progression 01/2023 - 12/2009
5	Lymphoma (Lymphomas) 01/2018 - 06/2005
4	Melanoma (Melanoma, Malignant) 01/2020 - 08/2002
4	Residual Neoplasm 01/2018 - 05/2012
4	Intellectual Disability (Idiocy) 01/2017 - 01/2012
3	Starvation 05/2024 - 02/2014
3	Ependymoma 08/2021 - 04/2016
3	Thalassemia 01/2017 - 11/2012
3	Primitive Neuroectodermal Tumors (PNET) 02/2016 - 10/2003
3	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2016 - 10/2002
2	Inflammation (Inflammations) 01/2023 - 12/2017
2	Typical Teratoid Rhabdoid Tumor 01/2023 - 01/2022
2	Rhabdoid Tumor (Rhabdoid Tumors) 01/2022 - 01/2018
2	Necrosis 12/2020 - 11/2018
2	Pituitary Neoplasms (Pituitary Adenoma) 03/2018 - 01/2018
2	Neuroblastoma 04/2017 - 05/2004
2	Hypoxia (Hypoxemia) 09/2014 - 04/2010

Drug/Important Bio-Agent (IBA)

47	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2002
40	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2024 - 10/2009
37	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 08/2002
33	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2005
30	Messenger RNA (mRNA)IBA 02/2022 - 09/2003
28	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 09/2006
14	Alkylating AgentsIBA 05/2024 - 12/2007
14	MethyltransferasesIBA 01/2024 - 01/2005
11	Histones (Histone)IBA 05/2024 - 07/2008
10	ErbB Receptors (EGF Receptor)IBA 01/2021 - 10/2002
8	Phosphotransferases (Kinase)IBA 05/2024 - 10/2003
7	O-(6)-methylguanineIBA 01/2024 - 01/2005
7	RNA (Ribonucleic Acid)IBA 11/2021 - 08/2006
7	Lomustine (CCNU)FDA Link 10/2021 - 09/2006
7	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 02/2005
7	Codon (Codons)IBA 12/2018 - 04/2004
7	MicroRNAs (MicroRNA)IBA 12/2016 - 05/2010
6	ChromatinIBA 01/2023 - 01/2012
6	Amino Acids FDA Link 04/2015 - 11/2006
6	O(6)-Methylguanine-DNA MethyltransferaseIBA 07/2014 - 03/2009
5	Carrier Proteins (Binding Protein)IBA 05/2024 - 04/2004
5	Long Noncoding RNAIBA 11/2023 - 01/2019
5	LigandsIBA 01/2020 - 12/2008
5	epidermal growth factor receptor VIIIIBA 11/2019 - 10/2013
5	Decitabine FDA Link 06/2012 - 03/2004
5	sodium bisulfite FDA Link 05/2010 - 11/2006
4	InterferonsIBA 10/2023 - 04/2014
4	ProteomeIBA 01/2023 - 03/2010
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 01/2016
4	beta CateninIBA 04/2018 - 08/2002
4	Procarbazine (Matulane)FDA Link 09/2012 - 10/2002
4	Complementary DNA (cDNA)IBA 11/2006 - 07/2004
3	Mitogen-Activated Protein KinasesIBA 10/2023 - 02/2010
3	Histone Deacetylase InhibitorsIBA 01/2023 - 03/2004
3	CytokinesIBA 01/2020 - 08/2011
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2020 - 10/2003
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020 - 10/2003
3	AcidsIBA 02/2015 - 04/2011
3	Vincristine (Oncovin)FDA LinkGeneric 09/2012 - 10/2002
3	Small Interfering RNA (siRNA)IBA 08/2011 - 05/2008
3	NestinIBA 03/2011 - 04/2010
3	trichostatin A (A 300)IBA 06/2010 - 03/2004
2	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 06/2022
2	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 04/2024 - 12/2023
2	SteamIBA 04/2024 - 12/2023
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2023 - 12/2009
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023 - 11/2019
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2023 - 01/2018
2	CateninsIBA 06/2022 - 01/2012
2	Immune Checkpoint InhibitorsIBA 05/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 02/2022 - 04/2010
2	alpha-hydroxyglutarateIBA 01/2021 - 11/2018
2	Interferon Type IIBA 01/2020 - 12/2017
2	TOR Serine-Threonine KinasesIBA 01/2020 - 11/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 02/2016
2	Complement System Proteins (Complement)IBA 11/2018 - 12/2010
2	Formaldehyde (Formol)FDA Link 03/2018 - 05/2015
2	ParaffinIBA 03/2018 - 05/2015
2	SteroidsIBA 01/2018 - 01/2012
2	NF-kappa B (NF-kB)IBA 01/2018 - 03/2007
2	PeroxiredoxinsIBA 01/2018 - 08/2013
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 07/2002
2	Methionine (L-Methionine)FDA Link 11/2016 - 11/2006
2	LuciferasesIBA 01/2016 - 01/2014
2	DNA Repair EnzymesIBA 07/2014 - 01/2005
2	thiamine triphosphorate (TTP)IBA 12/2013 - 04/2004

Therapy/Procedure

47	Therapeutics 12/2023 - 02/2003
39	Drug Therapy (Chemotherapy) 05/2024 - 10/2002
22	Radiotherapy 05/2024 - 10/2002
11	Chemoradiotherapy 06/2022 - 10/2008
5	Immunotherapy 01/2023 - 01/2015
2	Molecular Targeted Therapy 11/2019 - 07/2002
2	Precision Medicine 07/2017 - 01/2010